Building a tuberculosis-free world: The Lancet Commission on tuberculosis

MJA Reid, N Arinaminpathy, A Bloom, BR Bloom… - The Lancet, 2019 - thelancet.com
Executive summary Tuberculosis can be treated, prevented, and cured. Rapid, sustained
declines in tuberculosis deaths in many countries during the past 50 years provide …

Latent Mycobacterium tuberculosis Infection

H Getahun, A Matteelli, RE Chaisson… - New England Journal …, 2015 - Mass Medical Soc
Latent Mycobacterium tuberculosis Infection | New England Journal of Medicine Skip to main
content The New England Journal of Medicine homepage Advanced Search SEARCH …

The ongoing challenge of latent tuberculosis

H Esmail, CE Barry 3rd, DB Young… - … Transactions of the …, 2014 - royalsocietypublishing.org
The global health community has set itself the task of eliminating tuberculosis (TB) as a
public health problem by 2050. Although progress has been made in global TB control, the …

[HTML][HTML] Treatment practices, outcomes, and costs of multidrug-resistant and extensively drug-resistant tuberculosis, United States, 2005–2007

SM Marks, J Flood, B Seaworth… - Emerging infectious …, 2014 - ncbi.nlm.nih.gov
To describe factors associated with multidrug-resistant (MDR), including extensively-drug-
resistant (XDR), tuberculosis (TB) in the United States, we abstracted inpatient, laboratory …

Management of tuberculosis infection: current situation, recent developments and operational challenges

G Agbota, M Bonnet, C Lienhardt - Pathogens, 2023 - mdpi.com
Tuberculosis infection (TBI) is defined as a state of infection in which individuals host live
Mycobacterium tuberculosis with or without clinical signs of active TB. It is now understood …

Actualización en el diagnóstico y tratamiento de la tuberculosis pulmonar

JAC Luna - Revista Clínica Española, 2016 - Elsevier
La tuberculosis (TB) sigue siendo la enfermedad infecciosa humana más importante que
existe. El diagnóstico actual de la TB sigue basándose en la presentación clínica, los …

A scoping review of cost-effectiveness of screening and treatment for latent tuberculosis infection in migrants from high-incidence countries

L Zammarchi, G Casadei, M Strohmeyer… - BMC health services …, 2015 - Springer
Background In low-incidence countries, most tuberculosis (TB) cases occur among migrants
and are caused by reactivation of latent tuberculosis infection (LTBI) acquired in the country …

Cost-effectiveness of testing and treatment for latent tuberculosis infection in residents born outside the United States with and without medical comorbidities in a …

A Tasillo, JA Salomon, TA Trikalinos… - JAMA internal …, 2017 - jamanetwork.com
Importance Testing for and treating latent tuberculosis infection (LTBI) is among the main
strategies to achieve TB elimination in the United States. The best approach to testing …

Tuberculosis in jails and prisons: United States, 2002− 2013

LA Lambert, LR Armstrong… - … journal of public …, 2016 - ajph.aphapublications.org
Objectives. To describe cases and estimate the annual incidence of tuberculosis in
correctional facilities. Methods. We analyzed 2002 to 2013 National Tuberculosis …

Cost-effectiveness of 3 months of weekly rifapentine and isoniazid compared with other standard treatment regimens for latent tuberculosis infection: a decision …

TN Doan, GJ Fox, MT Meehan, N Scott… - Journal of …, 2019 - academic.oup.com
Background Latent tuberculosis infection (LTBI) is a critical driver of the global burden of
active TB, and therefore LTBI treatment is key for TB elimination. Treatment regimens for …